{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:52:36Z","timestamp":1788324756547,"version":"build-2803163510"},"reference-count":37,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T00:00:00Z","timestamp":1720742400000},"content-version":"unspecified","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Key R&D Program of China","award":["2017YFC1310103"],"award-info":[{"award-number":["2017YFC1310103"]}]},{"name":"STI2030-Major Projects","award":["2021ZD0201802"],"award-info":[{"award-number":["2021ZD0201802"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,7,1]]},"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>The efficacy of multitarget neuroprotective drug DL-3-n-butylphthalide (NBP) in improving cognitive function has been confirmed in patients with vascular cognitive impairment without dementia. However, its efficacy in patients with symptomatic predementia phase of Alzheimer\u2019s disease remains uncertain. This study aims to evaluate the efficacy and safety of NBP in improving cognitive function in patients with mild cognitive impairment (MCI) through a clinical randomised controlled trail.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and analysis<\/jats:title><jats:p>This study is a 12-month, randomised, double-blind, placebo-controlled, multicentric trial, involving 270 patients with MCI. Subjects are randomly assigned to receive either NBP soft capsule (200\u2009mg, three times per day) or placebo with an allocation ratio of 1:1. The efficacy and safety of NBP are assessed by comparing the results of neuropsychological, neuroimaging and laboratory tests between the two groups. The primary endpoint is the change in Alzheimer\u2019s Disease Assessment Scale-Cognitive Subscale after 12 months. All patients will be monitored for adverse events.<\/jats:p><\/jats:sec><jats:sec><jats:title>Ethics and dissemination<\/jats:title><jats:p>This study involving human participants has been reviewed and approved by Ethics Committee of Xuan Wu Hospital (No.2017058). The participants provide their written informed consent to participate in this study. Results will be published in peer-reviewed medical journals and disseminated to healthcare professionals at local and international conferences.<\/jats:p><\/jats:sec><jats:sec><jats:title>Protocol version<\/jats:title><jats:p>V 3.0, 3 September 2022.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration number<\/jats:title><jats:p>ChiCTR1800018362.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2023-082404","type":"journal-article","created":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T09:00:55Z","timestamp":1720861255000},"page":"e082404","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy and safety of butylphthalide in patients with mild cognitive impairment: a multicentre, randomised, double-blind, placebo-controlled trial (EBMCI study)"],"prefix":"10.1136","volume":"14","author":[{"given":"Pin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heya","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruina","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boye","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirong","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7380-7451","authenticated-orcid":false,"given":"Cuibai","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,7,13]]},"reference":[{"key":"2024082721252891000_14.7.e082404.1","doi-asserted-by":"publisher","DOI":"10.2471\/blt.15.167726"},{"key":"2024082721252891000_14.7.e082404.2","unstructured":"Gauthier S-N , Morais JA , Webster C . World Alzheimer Report 2021: Journey through the Diagnosis of Dementia. London, England: Alzheimer\u2019s Disease International, 2021."},{"key":"2024082721252891000_14.7.e082404.3","doi-asserted-by":"publisher","DOI":"10.1016\/s2468-2667(20)30185-7"},{"key":"2024082721252891000_14.7.e082404.4","unstructured":"World Health Organization . Global Status Report on the Public Health Response to Dementia 2017-2025. Geneva: World Health Organization, 2021:27."},{"key":"2024082721252891000_14.7.e082404.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2017.12.006"},{"key":"2024082721252891000_14.7.e082404.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30427-1"},{"key":"2024082721252891000_14.7.e082404.7","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70291-0"},{"key":"2024082721252891000_14.7.e082404.8","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/ana.24792","article-title":"Episodic memory of odors Stratifies Alzheimer biomarkers in normal elderly","volume":"80","author":"Dhilla Albers","year":"2016","journal-title":"Ann Neurol"},{"key":"2024082721252891000_14.7.e082404.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp0910237"},{"key":"2024082721252891000_14.7.e082404.10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1212\/WNL.0000000000000055","article-title":"Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal","volume":"82","author":"Roberts","year":"2014","journal-title":"Neurology (ECronicon)"},{"key":"2024082721252891000_14.7.e082404.11","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1212\/WNL.0000000000004826","article-title":"Practice guideline update summary: mild cognitive impairment: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of neurology","volume":"90","author":"Petersen","year":"2018","journal-title":"Neurology (ECronicon)"},{"key":"2024082721252891000_14.7.e082404.12","doi-asserted-by":"publisher","DOI":"10.1159\/000354370"},{"key":"2024082721252891000_14.7.e082404.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJ-Moa2212948"},{"key":"2024082721252891000_14.7.e082404.14","doi-asserted-by":"publisher","DOI":"10.1038\/s41583-019-0132-6"},{"key":"2024082721252891000_14.7.e082404.15","doi-asserted-by":"crossref","DOI":"10.1126\/science.aav9518","article-title":"Amyloid \u0392 Oligomers Constrict human Capillaries in Alzheimer\u2019s disease via signaling to Pericytes","volume":"365","author":"Nortley","year":"2019","journal-title":"Science"},{"key":"2024082721252891000_14.7.e082404.16","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201709069"},{"key":"2024082721252891000_14.7.e082404.17","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1002\/med.21722","article-title":"Cerebrolysin in the therapy of mild cognitive impairment and dementia due to Alzheimer\u2019s disease: 30 years of clinical use","volume":"41","author":"Gavrilova","year":"2021","journal-title":"Med Res Rev"},{"key":"2024082721252891000_14.7.e082404.18","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s12640-018-9905-3","article-title":"L-3-N-Butylphthalide regulates proliferation, migration, and differentiation of neural stem cell in vitro and promotes Neurogenesis in APP\/Ps1 mouse model by regulating BDNF\/Trkb\/CREB\/AKT pathway","volume":"34","author":"Lei","year":"2018","journal-title":"Neurotox Res"},{"key":"2024082721252891000_14.7.e082404.19","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1007\/s12035-022-02777-8","article-title":"Camkii\u03b1 signaling is required for the Neuroprotective effects of Dl-3-N-Butylphthalide in Alzheimer\u2019s disease","volume":"59","author":"Li","year":"2022","journal-title":"Mol Neurobiol"},{"key":"2024082721252891000_14.7.e082404.20","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5012341","article-title":"A review of recent advances in Neuroprotective potential of 3-N-Butylphthalide and its derivatives","volume":"2016","author":"Abdoulaye","year":"2016","journal-title":"Biomed Res Int"},{"key":"2024082721252891000_14.7.e082404.21","doi-asserted-by":"crossref","DOI":"10.3892\/etm.2022.11248","article-title":"Dl-3-N-Butylphthalide Alleviates cognitive impairment in Amyloid precursor protein\/Presenilin 1 transgenic mice by regulating the striatal-enriched protein tyrosine phosphatase\/ERK\/cAMP-response element-binding protein signaling pathway","volume":"23","author":"Zhao","year":"2022","journal-title":"Exp Ther Med"},{"key":"2024082721252891000_14.7.e082404.22","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-021-02516-x","article-title":"DL-3-N-Butylphthalide promotes hippocampal Neurogenesis and reduces mossy fiber sprouting in chronic temporal lobe epilepsy rats","volume":"22","author":"Zhao","year":"2022","journal-title":"BMC Neurol"},{"key":"2024082721252891000_14.7.e082404.23","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.620176","article-title":"Dl-3-N-Butylphthalide reduces cognitive deficits and Alleviates neuropathology in P301S Tau transgenic mice","volume":"15","author":"Chang","year":"2021","journal-title":"Front Neurosci"},{"key":"2024082721252891000_14.7.e082404.24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jalz.2015.04.010","article-title":"The effects of DL-3-N-Butylphthalide in patients with vascular cognitive impairment without dementia caused by subcortical ischemic small vessel disease: A Multicentre, randomized, double-blind, placebo-controlled trial","volume":"12","author":"Jia","year":"2016","journal-title":"Alzheimers Dement"},{"key":"2024082721252891000_14.7.e082404.25","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3233\/JAD-201381","article-title":"Donepezil combined with DL-3-N-Butylphthalide delays cognitive decline in patients with mild to moderate Alzheimer\u2019s disease: A multicenter, prospective cohort study","volume":"80","author":"Wang","year":"2021","journal-title":"JAD"},{"key":"2024082721252891000_14.7.e082404.26","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-3-201302050-00583"},{"key":"2024082721252891000_14.7.e082404.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.03.008"},{"key":"2024082721252891000_14.7.e082404.28","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(75)90026-6"},{"key":"2024082721252891000_14.7.e082404.29","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.140.6.566"},{"key":"2024082721252891000_14.7.e082404.30","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/01616412.2016.1268775","article-title":"Dl-3-N-Butylphthalide can improve the cognitive function of patients with acute ischemic stroke: a prospective intervention study","volume":"39","author":"Yan","year":"2017","journal-title":"Neurol Res"},{"key":"2024082721252891000_14.7.e082404.31","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3233\/JAD-201381","article-title":"Donepezil combined with DL-3-N-Butylphthalide delays cognitive decline in patients with mild to moderate Alzheimer\u2019s disease: A multicenter, prospective cohort study","volume":"80","author":"Wang","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"2024082721252891000_14.7.e082404.32","first-page":"231","article-title":"The cognitive Subscale of Alzheimer\u2019s disease assessment scale, Chinese version in staging of Alzheimer disease","volume":"18","author":"Wang","year":"2004","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"2024082721252891000_14.7.e082404.33","first-page":"S10","article-title":"The neuropsychiatric inventory: assessing psychopathology in dementia patients","volume":"48","author":"Cummings","year":"1997","journal-title":"Neurol (ECronicon)"},{"key":"2024082721252891000_14.7.e082404.34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1995.tb05811.x"},{"key":"2024082721252891000_14.7.e082404.35","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1994.03950010051007"},{"key":"2024082721252891000_14.7.e082404.36","unstructured":"Reitan RM , Wolfson D . The Halstead-Reitan Neuropsychological Test Battery: Therapy and Clinical Interpretation. Tucson, AZ: Neuropsychological Press, 1985."},{"key":"2024082721252891000_14.7.e082404.37","unstructured":"Wechsler D . Administration and Scoring Manual for the WAIS-III. San Antonio, TX: Psychological Corporation, 1997."}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-082404","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T04:27:43Z","timestamp":1724819263000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-082404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":37,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7,13]]},"published-print":{"date-parts":[[2024,7]]}},"alternative-id":["10.1136\/bmjopen-2023-082404"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-082404","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]}}}